Montgomery v. TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC. et al
Plaintiff: Montgomery and Antigone Montgomery
Defendant: TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC, Bayer Healthcare Pharmaceuticals Inc., Ivax LLC, JANSSEN PHARMACEUTICALS, INC., TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC., Janssen Research & Development, LLC, ORTHO-MCNEIL PHARMACEUTICALS, LLC, Teva Global Respiratory Research, LLC, Centocor Research & Development Inc, Ortho-McNeil-Janssen Pharmaceuticals, Inc, Ivax Corporation, Alza Corporation, Johnson & Johnson Research & Development, L.L.C, Bayer Pharmaceuticals Corporation, Janssen Ortho LLC, TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D INC, Janssen Research and Developement, LLC, Janssen Pharmaceuticals Inc., ORTHO- MCNEIL-JANSSEN PHARMACEUTICALS, INC. nka JANSSEN PHARMACEUTICALS, INC., Johnson & Johnson, Centocor Research & Development, Inc. and Bayer Healthcare, LLC
Case Number: FLS/1:20-CV-23380
Filed: August 13, 2020
Court: Judicial Panel on Multidistrict Litigation
Presiding Judge: Darrin P Gayles
Nature of Suit: Other
RSS RSS Track this Docket
Docket Report

This docket was last retrieved on December 16, 2020. A more recent docket listing may be available from PACER.

Date Filed Document Text
December 16, 2020 Filing 29 OFFICIAL TRANSCRIPT of Hearing held on 12/3/2020 before the Panel at Washington, DC. Court Reporter/Transcriber Bryan Wayne, 333 Constitution Avenue, N.W., Room 4704-A, Washington, DC 20001, bryan_wayne@dcd.uscourts.gov. Transcript may be viewed at the Panel's office or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Notice of Redaction due 12/23/2020. Redaction Request due 1/6/2021. Redacted Transcript Deadline set for 1/16/2021. Release of Transcript Restriction set for 3/16/2021.Signed by Clerk of the Panel John W. Nichols on 12/16/2020. Associated Cases: MDL No. 2973, ALN/2:20-cv-00993, CAS/3:20-cv-01266, FLM/2:20-cv-00330, FLM/5:20-cv-00390, FLS/0:20-cv-61721, FLS/1:20-cv-23144, FLS/1:20-cv-23380, FLS/1:20-cv-23500, MOW/4:20-cv-00543, MOW/4:20-cv-00544, NCM/1:20-cv-00718, NCM/1:20-cv-00769, NJ/3:20-cv-06070, NJ/3:20-cv-07079, NJ/3:20-cv-07750, NJ/3:20-cv-07753, NJ/3:20-cv-07756, NJ/3:20-cv-07758, NJ/3:20-cv-08074, NJ/3:20-cv-09530, NJ/3:20-cv-10080, NJ/3:20-cv-10341, NJ/3:20-cv-10342, NJ/3:20-cv-10960, NJ/3:20-cv-10966, NJ/3:20-cv-10968, NJ/3:20-cv-11440, NJ/3:20-cv-11912, NJ/3:20-cv-11913, NJ/3:20-cv-11919, NJ/3:20-cv-11921, NJ/3:20-cv-12264, NJ/3:20-cv-12328, NJ/3:20-cv-12421, NJ/3:20-cv-12605, NJ/3:20-cv-12608, OHN/4:20-cv-01984, OHS/1:20-cv-00675, PAE/2:20-cv-02147, PAE/2:20-cv-02150, PAE/2:20-cv-02183, PAE/2:20-cv-02207, PAE/2:20-cv-02234, PAE/2:20-cv-02871, PAE/2:20-cv-03056, PAE/2:20-cv-03345, PAE/2:20-cv-04021, PAE/2:20-cv-04024, PAE/2:20-cv-04053, PAE/2:20-cv-04133, PAE/2:20-cv-04153, PAE/2:20-cv-04157, PAE/2:20-cv-04158, PAE/2:20-cv-04160, PAE/2:20-cv-04162, PAE/2:20-cv-04179, PAE/2:20-cv-04389, PAE/2:20-cv-04394, PAE/2:20-cv-04397, PAE/2:20-cv-04423, PAE/2:20-cv-04488, WIE/2:20-cv-01256, WIE/2:20-cv-01309 (RH)
December 15, 2020 Opinion or Order Filing 28 TRANSFER ORDER re: pldg. ( #4 in MDL No. 2973), ( #10 in MDL No. 2973), ( #1 in MDL No. 2973) Transferring 39 action(s) to Judge Brian R. Martinotti in the New Jersey.Signed by Judge Karen K. Caldwell, Chair, PANEL ON MULTIDISTRICT LITIGATION, on 12/15/2020. Associated Cases: MDL No. 2973 et al. (TF)
November 16, 2020 Filing 27 SUPPLEMENTAL NOTICE OF HEARING SESSION re: pldg. (15 in ALN/2:20-cv-00993, 19 in CAS/3:20-cv-01266, 16 in FLM/2:20-cv-00330, 12 in FLM/5:20-cv-00390, 12 in FLS/0:20-cv-61721, 20 in FLS/1:20-cv-23144, 19 in FLS/1:20-cv-23380, 12 in FLS/1:20-cv-23500, #102 in MDL No. 2973, 21 in MOW/4:20-cv-00543, 21 in MOW/4:20-cv-00544, 12 in NCM/1:20-cv-00718, 12 in NCM/1:20-cv-00769, 16 in NJ/3:20-cv-06070, 15 in NJ/3:20-cv-07079, 17 in NJ/3:20-cv-07750, 17 in NJ/3:20-cv-07753, 17 in NJ/3:20-cv-07756, 16 in NJ/3:20-cv-07758, 16 in NJ/3:20-cv-08074, 16 in NJ/3:20-cv-09530, 21 in NJ/3:20-cv-10080, 23 in NJ/3:20-cv-10341, 23 in NJ/3:20-cv-10342, 21 in NJ/3:20-cv-10960, 21 in NJ/3:20-cv-10966, 21 in NJ/3:20-cv-10968, 21 in NJ/3:20-cv-11440, 21 in NJ/3:20-cv-11912, 21 in NJ/3:20-cv-11913, 21 in NJ/3:20-cv-11919, 21 in NJ/3:20-cv-11921, 21 in NJ/3:20-cv-12264, 15 in NJ/3:20-cv-12328, 17 in NJ/3:20-cv-12421, 16 in NJ/3:20-cv-12605, 16 in NJ/3:20-cv-12608, 6 in OHN/4:20-cv-01984, 12 in OHS/1:20-cv-00675, 10 in PAE/2:20-cv-02147, 10 in PAE/2:20-cv-02150, 10 in PAE/2:20-cv-02183, 10 in PAE/2:20-cv-02207, 9 in PAE/2:20-cv-02234, 10 in PAE/2:20-cv-02871, 10 in PAE/2:20-cv-03056, 9 in PAE/2:20-cv-03345, 10 in PAE/2:20-cv-04021, 9 in PAE/2:20-cv-04024, 14 in PAE/2:20-cv-04053, 13 in PAE/2:20-cv-04133, 13 in PAE/2:20-cv-04153, 8 in PAE/2:20-cv-04157, 8 in PAE/2:20-cv-04158, 9 in PAE/2:20-cv-04160, 8 in PAE/2:20-cv-04162, 13 in PAE/2:20-cv-04179, 8 in PAE/2:20-cv-04389, 9 in PAE/2:20-cv-04394, 8 in PAE/2:20-cv-04397, 8 in PAE/2:20-cv-04423, 9 in PAE/2:20-cv-04488, 13 in WIE/2:20-cv-01256, 13 in WIE/2:20-cv-01309) Signed by Clerk of the Panel John W. Nichols on 11/16/2020. Associated Cases: MDL No. 2973 et al. (dld)
November 9, 2020 Filing 26 NOTICE OF PRESENTATION OF ORAL ARGUMENT re: pldg. ( 1 in MDL No. 2973), ( 102 in MDL No. 2973) Filed by Robert Bruce Hurley, Jr on behalf of Defendants Alza Corporation, #et al.Bayer HealthCare LLC, Bayer HealthCare Pharmaceuticals, Inc,, Janssen Ortho LLC, Janssen Research & Development LLC, Johnson & Johnson, Ortho-McNeil Pharmaceutical, Inc., JANSSEN PHARMACEUTICALS, INC., BAYER CORPORATION, BAYER US L.L.C., Centocor Research & Development, Inc. #[Suppress List] (Attachments: #1 Other Parties Represented, #2 Schedule of Actions, #3 Proof of Service) Associated Cases: MDL No. 2973 et al. (Hurley, Robert) ADDED MDL LINK Modified on 11/10/2020 (RH).
November 6, 2020 Filing 25 NOTICE OF PRESENTATION OF ORAL ARGUMENT re: pldg. (19 in CAS/3:20-cv-01266, 19 in FLS/1:20-cv-23380, #102 in MDL No. 2973, 17 in NJ/3:20-cv-12421), (18 in CAS/3:20-cv-01266, 18 in FLS/1:20-cv-23380, #86 in MDL No. 2973, 16 in NJ/3:20-cv-12421) Filed by Melanie H. Muhlstock on behalf of Plaintiffs Joanne Jackson, #et al.ELIZABETH LAFAVE, Antigone Montgomery #[Suppress List] (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2973, CAS/3:20-cv-01266, FLS/1:20-cv-23380, NJ/3:20-cv-12421 (Muhlstock, Melanie)
October 29, 2020 Filing 24 CERTIFICATE OF SERVICE (AMENDED) re: pldg. ( #108 in MDL No. 2973) Filed by Plaintiffs JAMES DOBBINS, SHERRY DOBBINS -- Associated Cases: MDL No. 2973 et al. (London, Michael)
October 28, 2020 Filing 23 CERTIFICATE OF SERVICE (AMENDED) re: pldg. (17 in ALN/2:20-cv-00993, 21 in CAS/3:20-cv-01266, 18 in FLM/2:20-cv-00330, 13 in FLM/5:20-cv-00390, 13 in FLS/0:20-cv-61721, 3 in FLS/0:20-cv-62068, 23 in FLS/1:20-cv-23144, 21 in FLS/1:20-cv-23380, 13 in FLS/1:20-cv-23500, 5 in ILN/1:20-cv-05989, #108 in MDL No. 2973, 23 in MOW/4:20-cv-00543, 23 in MOW/4:20-cv-00544, 13 in NCM/1:20-cv-00718, 13 in NCM/1:20-cv-00769, 17 in NJ/2:20-cv-07079, 18 in NJ/3:20-cv-06070, 19 in NJ/3:20-cv-07750, 19 in NJ/3:20-cv-07753, 19 in NJ/3:20-cv-07756, 18 in NJ/3:20-cv-07758, 18 in NJ/3:20-cv-08074, 18 in NJ/3:20-cv-09530, 23 in NJ/3:20-cv-10080, 25 in NJ/3:20-cv-10341, 25 in NJ/3:20-cv-10342, 23 in NJ/3:20-cv-10960, 23 in NJ/3:20-cv-10966, 23 in NJ/3:20-cv-10968, 23 in NJ/3:20-cv-11440, 23 in NJ/3:20-cv-11912, 23 in NJ/3:20-cv-11913, 23 in NJ/3:20-cv-11919, 23 in NJ/3:20-cv-11921, 23 in NJ/3:20-cv-12264, 17 in NJ/3:20-cv-12328, 18 in NJ/3:20-cv-12421, 7 in NJ/3:20-cv-12547, 18 in NJ/3:20-cv-12605, 18 in NJ/3:20-cv-12608, 10 in NJ/3:20-cv-13596, 7 in NJ/3:20-cv-13940, 5 in NJ/3:20-cv-14439, 3 in NJ/3:20-cv-14447, 3 in NJ/3:20-cv-14448, 3 in NJ/3:20-cv-14450, 3 in NJ/3:20-cv-14452, 3 in NJ/3:20-cv-14663, 3 in NJ/3:20-cv-14668, 3 in NJ/3:20-cv-14670, 7 in OHN/4:20-cv-01984, 13 in OHS/1:20-cv-00675, 4 in OHS/1:20-cv-00755, 11 in PAE/2:20-cv-02147, 11 in PAE/2:20-cv-02150, 11 in PAE/2:20-cv-02183, 11 in PAE/2:20-cv-02207, 10 in PAE/2:20-cv-02234, 11 in PAE/2:20-cv-02871, 11 in PAE/2:20-cv-03056, 10 in PAE/2:20-cv-03345, 11 in PAE/2:20-cv-04021, 10 in PAE/2:20-cv-04024, 15 in PAE/2:20-cv-04053, 14 in PAE/2:20-cv-04133, 14 in PAE/2:20-cv-04153, 9 in PAE/2:20-cv-04157, 9 in PAE/2:20-cv-04158, 10 in PAE/2:20-cv-04160, 9 in PAE/2:20-cv-04162, 14 in PAE/2:20-cv-04179, 9 in PAE/2:20-cv-04389, 10 in PAE/2:20-cv-04394, 9 in PAE/2:20-cv-04397, 9 in PAE/2:20-cv-04423, 10 in PAE/2:20-cv-04488, 7 in PAE/2:20-cv-04726, 4 in PAE/2:20-cv-04773, 4 in PAE/2:20-cv-04775, 4 in PAE/2:20-cv-04777, 4 in PAE/2:20-cv-04778, 4 in PAE/2:20-cv-04779, 4 in PAE/2:20-cv-04787, 4 in PAE/2:20-cv-04788, 4 in PAE/2:20-cv-04789, 4 in PAE/2:20-cv-04790, 4 in PAE/2:20-cv-04791, 4 in PAE/2:20-cv-04929, 3 in PAE/2:20-cv-04936, 3 in PAE/2:20-cv-04945, 14 in WIE/2:20-cv-01256, 14 in WIE/2:20-cv-01309) Filed by Plaintiffs JAMES DOBBINS, SHERRY DOBBINS -- Associated Cases: MDL No. 2973 et al. (London, Michael)
October 23, 2020 Filing 22 MINUTE ORDER CLOSING BRIEFING re: pldg. ( #4 in MDL No. 2973), ( #10 in MDL No. 2973), ( #1 in MDL No. 2973) Briefing in this matter is now closed. The parties to actions on the motion(s) remain under a duty, pursuant to Panel Rules 6.1(f) and 6.2(d), to notify the Clerk of the Panel promptly of potential tag-along actions, as well as any development that moots the motion or fully disposes of any action on the motion. Parties in any potential tag-along action may file an Interested Party response, but must do so promptly, and in any event, no later than the Thursday prior to the hearing session at which the motion for transfer is to be heard by the Panel.Signed by Clerk of the Panel John W. Nichols on 10/23/2020. Associated Cases: MDL No. 2973 et al. (TF)
October 22, 2020 Filing 21 REPLY TO RESPONSE TO MOTION FOR TRANSFER re: pldg. ( #1 in MDL No. 2973) Filed by Plaintiffs JAMES DOBBINS, SHERRY DOBBINS (Attachments: #1 Proof of Service) Associated Cases: MDL No. 2973 et al. (London, Michael)
October 22, 2020 Filing 20 CERTIFICATE OF SERVICE (AMENDED) re: pldg. (8 in ALN/2:20-cv-00993, 37 in MDL No. 2973, 8 in NJ/3:20-cv-09530, 10 in NJ/3:20-cv-10960, 10 in NJ/3:20-cv-10966, 10 in NJ/3:20-cv-10968, 10 in NJ/3:20-cv-11912, 10 in NJ/3:20-cv-11913, 10 in NJ/3:20-cv-11919, 10 in NJ/3:20-cv-11921, 8 in NJ/3:20-cv-12328), (5 in ALN/2:20-cv-00993, 7 in CAS/3:20-cv-01266, 7 in FLS/1:20-cv-23144, 8 in FLS/1:20-cv-23380, 31 in MDL No. 2973, 7 in MOW/4:20-cv-00543, 7 in MOW/4:20-cv-00544, 7 in NJ/3:20-cv-07750, 7 in NJ/3:20-cv-07753, 7 in NJ/3:20-cv-07756, 7 in NJ/3:20-cv-07758, 7 in NJ/3:20-cv-08074, 5 in NJ/3:20-cv-09530, 6 in NJ/3:20-cv-10080, 7 in NJ/3:20-cv-10341, 7 in NJ/3:20-cv-10342, 5 in NJ/3:20-cv-10960, 5 in NJ/3:20-cv-10966, 5 in NJ/3:20-cv-10968, 5 in NJ/3:20-cv-11912, 5 in NJ/3:20-cv-11913, 5 in NJ/3:20-cv-11919, 5 in NJ/3:20-cv-11921, 6 in NJ/3:20-cv-12264, 5 in NJ/3:20-cv-12328, 7 in NJ/3:20-cv-12605, 7 in NJ/3:20-cv-12608), (7 in ALN/2:20-cv-00993, 10 in FLS/1:20-cv-23144, 34 in MDL No. 2973, 9 in NJ/3:20-cv-07750, 9 in NJ/3:20-cv-07753, 9 in NJ/3:20-cv-07756, 9 in NJ/3:20-cv-07758, 9 in NJ/3:20-cv-08074, 7 in NJ/3:20-cv-09530, 8 in NJ/3:20-cv-10080, 9 in NJ/3:20-cv-10341, 9 in NJ/3:20-cv-10342, 7 in NJ/3:20-cv-10960, 7 in NJ/3:20-cv-10966, 7 in NJ/3:20-cv-10968, 7 in NJ/3:20-cv-11912, 7 in NJ/3:20-cv-11913, 7 in NJ/3:20-cv-11919, 7 in NJ/3:20-cv-11921, 8 in NJ/3:20-cv-12264, 7 in NJ/3:20-cv-12328, 9 in NJ/3:20-cv-12605, 9 in NJ/3:20-cv-12608), (11 in CAS/3:20-cv-01266, 41 in MDL No. 2973), ( 39 in MDL No. 2973, 10 in MOW/4:20-cv-00543, 10 in MOW/4:20-cv-00544)( 56 in MDL No. 2973) Filed by Defendants Teva Branded Pharmaceutical Products R&D, Inc., Teva Pharmaceuticals USA, Inc., IVAX LLC, Baker Norton U.S., Inc., and Baker Norton Pharmaceuticals, Inc. -- Associated Cases: MDL No. 2973 et al. (McIntosh, Thomas) Modified on 10/22/2020 (TF). REMOVED DUPLICATE PARTIES. ADDED MDL LINK.
October 22, 2020 Opinion or Order Filing 19 HEARING ORDER re: pldg. ( #1 in MDL No. 2973) - SECTION A (DESIGNATED FOR ORAL ARGUMENT) PANEL HEARING set for 12/3/2020 in Washington, DC. Notices of Presentation or Waiver of Oral Argument due on or before 11/9/2020.#Notice of Presentation or Waiver of Oral Argument form (JPML form 9) can be downloaded from our website.Signed by Judge Karen K. Caldwell, Chair, PANEL ON MULTIDISTRICT LITIGATION, on 10/22/2020. Associated Cases: MDL No. 2973 et al. (RH)
October 15, 2020 Filing 18 RESPONSE IN SUPPORT -- (re: pldg. ( #1 in MDL No. 2973) ) Filed by Plaintiffs Joanne Jackson, #et al.ELIZABETH LAFAVE, Antigone Montgomery #[Suppress List] (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2973, CAS/3:20-cv-01266, FLS/1:20-cv-23380, NJ/3:20-cv-12421 (Silverman, Raymond)
October 15, 2020 Filing 17 RESPONSE -- (re: pldg. ( 1 in MDL No. 2973) ) Filed by Defendants Teva Branded Pharmaceutical Products R&D, Inc., Teva Pharmaceuticals USA, Inc., IVAX LLC, Baker Norton U.S., Inc., and Baker Norton Pharmaceuticals, Inc. (Attachments: #1 Proof of Service) Associated Cases: MDL No. 2973 et al. (McIntosh, Thomas) Modified on 10/16/2020 (TF). REMOVED DUPLICATE PARTIES.
October 15, 2020 Filing 16 RESPONSE -- (re: pldg. ( 1 in MDL No. 2973) ) Filed by Defendants Bayer Corporation, Bayer Healthcare LLC, Bayer Healthcare Pharmaceuticals, Inc., and Bayer US LLC. (Attachments: #1 Proof of Service) Associated Cases: MDL No. 2973, CAS/3:20-cv-01266, FLM/2:20-cv-00330, FLS/1:20-cv-23144, FLS/1:20-cv-23380, MOW/4:20-cv-00543, MOW/4:20-cv-00544, PAE/2:20-cv-04053 (Hurley, Robert) Modified on 10/16/2020 (TF). REMOVED DUPLICATE PARTIES.
October 15, 2020 Filing 15 RESPONSE -- (re: pldg. ( 1 in MDL No. 2973) ) Filed by Defendant JANSSEN PHARMACEUTICALS, INC. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Exhibit G, #8 Exhibit H, #9 Exhibit I, #10 Proof of Service) Associated Cases: MDL No. 2973 et al. (Hurley, Robert) Modified on 10/16/2020 (TF). REMOVED DUPLICATE PARTIES.
October 13, 2020 Filing 14 CERTIFICATE OF SERVICE (AMENDED) re: pldg. (8 in ALN/2:20-cv-00993, 37 in MDL No. 2973, 8 in NJ/3:20-cv-09530, 10 in NJ/3:20-cv-10960, 10 in NJ/3:20-cv-10966, 10 in NJ/3:20-cv-10968, 10 in NJ/3:20-cv-11912, 10 in NJ/3:20-cv-11913, 10 in NJ/3:20-cv-11919, 10 in NJ/3:20-cv-11921, 8 in NJ/3:20-cv-12328), (5 in ALN/2:20-cv-00993, 7 in CAS/3:20-cv-01266, 7 in FLS/1:20-cv-23144, 8 in FLS/1:20-cv-23380, 31 in MDL No. 2973, 7 in MOW/4:20-cv-00543, 7 in MOW/4:20-cv-00544, 7 in NJ/3:20-cv-07750, 7 in NJ/3:20-cv-07753, 7 in NJ/3:20-cv-07756, 7 in NJ/3:20-cv-07758, 7 in NJ/3:20-cv-08074, 5 in NJ/3:20-cv-09530, 6 in NJ/3:20-cv-10080, 7 in NJ/3:20-cv-10341, 7 in NJ/3:20-cv-10342, 5 in NJ/3:20-cv-10960, 5 in NJ/3:20-cv-10966, 5 in NJ/3:20-cv-10968, 5 in NJ/3:20-cv-11912, 5 in NJ/3:20-cv-11913, 5 in NJ/3:20-cv-11919, 5 in NJ/3:20-cv-11921, 6 in NJ/3:20-cv-12264, 5 in NJ/3:20-cv-12328, 7 in NJ/3:20-cv-12605, 7 in NJ/3:20-cv-12608), (7 in ALN/2:20-cv-00993, 10 in FLS/1:20-cv-23144, 34 in MDL No. 2973, 9 in NJ/3:20-cv-07750, 9 in NJ/3:20-cv-07753, 9 in NJ/3:20-cv-07756, 9 in NJ/3:20-cv-07758, 9 in NJ/3:20-cv-08074, 7 in NJ/3:20-cv-09530, 8 in NJ/3:20-cv-10080, 9 in NJ/3:20-cv-10341, 9 in NJ/3:20-cv-10342, 7 in NJ/3:20-cv-10960, 7 in NJ/3:20-cv-10966, 7 in NJ/3:20-cv-10968, 7 in NJ/3:20-cv-11912, 7 in NJ/3:20-cv-11913, 7 in NJ/3:20-cv-11919, 7 in NJ/3:20-cv-11921, 8 in NJ/3:20-cv-12264, 7 in NJ/3:20-cv-12328, 9 in NJ/3:20-cv-12605, 9 in NJ/3:20-cv-12608), (11 in CAS/3:20-cv-01266, 41 in MDL No. 2973), ( 39 in MDL No. 2973, 10 in MOW/4:20-cv-00543, 10 in MOW/4:20-cv-00544) Filed by Defendants TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC., TEVA PHARMACEUTICALS USA, INC., IVAX LLC, BAKER NORTON PHARMACEUTICALS, BAKER NORTON U.S., INC. -- Associated Cases: MDL No. 2973 et al. (McIntosh, Thomas) Modified on 10/13/2020 (TF). REMOVED DUPLICATE PARTIES.
October 8, 2020 Filing 13 CORPORATE DISCLOSURE STATEMENT re: pldg. ( #1 in MDL No. 2973) -- Identifying Corporate Parent Bayer Corporation for BAYER HEALTHCARE PHARMACEUTICALS, INC, BAYER HEALTHCARE PHARMACEUTICALS, INC, BAYER HEALTHCARE PHARMACEUTICALS, INC., BAYER HEALTHCARE PHARMACEUTICALS, INC., BAYER HEALTHCARE PHARMACEUTICALS, INC., Bayer HealthCare Pharmaceuticals, Inc,, Bayer Healthcare Pharmaceuticals Inc., Bayer Healthcare Pharmaceuticals Inc., Bayer Healthcare Pharmaceuticals, Inc., Bayer Healthcare Pharmaceuticals, Inc., Bayer Healthcare Pharmaceuticals, Inc.. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2973, CAS/3:20-cv-01266, FLM/2:20-cv-00330, FLS/1:20-cv-23144, FLS/1:20-cv-23380, MOW/4:20-cv-00543, MOW/4:20-cv-00544, NJ/3:20-cv-10341, NJ/3:20-cv-10342, NJ/3:20-cv-11440, NJ/3:20-cv-12421, PAE/2:20-cv-04053 (Hurley, Robert)
October 8, 2020 Filing 12 CORPORATE DISCLOSURE STATEMENT re: pldg. ( 1 in MDL No. 2973) -- Identifying Corporate Parent Johnson & Johnson for ORTHO -MCNEIL PHARMACEUTICAL, INC. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2973 et al. (Hurley, Robert) Modified on 10/9/2020 (TF). REMOVED DUPLICATE PARTIES.
October 8, 2020 Filing 11 CORPORATE DISCLOSURE STATEMENT re: pldg. ( 1 in MDL No. 2973) -- Identifying Corporate Parent No Parent Corp. for JOHNSON & JOHNSON. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2973 et al. (Hurley, Robert) Modified on 10/9/2020 (TF). REMOVED DUPLICATE PARTIES.
October 8, 2020 Filing 10 CORPORATE DISCLOSURE STATEMENT re: pldg. ( 1 in MDL No. 2973) -- Identifying Corporate Parent Centocor Research & Development, Inc. for JANSSEN RESEARCH & DEVELOPMENT LLC. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2973 et al. (Hurley, Robert) Modified on 10/9/2020 (TF). REMOVED DUPLICATE PARTIES.
October 8, 2020 Filing 9 CORPORATE DISCLOSURE STATEMENT re: pldg. ( 1 in MDL No. 2973) -- Identifying Corporate Parent Johnson & Johnson for JANSSEN PHARMACEUTICALS INC. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2973 et al. (Hurley, Robert) Modified on 10/9/2020 (TF). REMOVED DUPLICATE PARTIES.
October 8, 2020 Filing 8 NOTICE OF APPEARANCE re: pldg.( 1 in MDL No. 2973) Filed by Thomas G McIntosh on behalf of Defendants TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC., TEVA PHARMACEUTICALS USA, INC., IVAX LLC, BAKER NORTON PHARMACEUTICALS, BAKER NORTON U.S., INC. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2973 et al. (McIntosh, Thomas) Modified on 10/9/2020 (TF). REMOVED DUPLICATE PARTIES.
October 8, 2020 Filing 7 CORPORATE DISCLOSURE STATEMENT re: pldg. ( 1 in MDL No. 2973) -- Identifying Corporate Parent OMJ PR Holdings for JANSSEN ORTHO LLC. Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2973 et al. (Hurley, Robert) Modified on 10/9/2020 (TF). REMOVED DUPLICATE PARTIES.
October 8, 2020 Filing 6 CORPORATE DISCLOSURE STATEMENT re: pldg. ( 1 in MDL No. 2973) -- Identifying Corporate Parent Johnson & Johnson for Centocor Research & Development Inc. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2973, CAS/3:20-cv-01266, FLS/1:20-cv-23380 (Hurley, Robert) Modified on 10/9/2020 (TF). REMOVED DUPLICATE PARTIES.
October 8, 2020 Filing 5 CORPORATE DISCLOSURE STATEMENT re: pldg. ( 1 in MDL No. 2973) -- Identifying Corporate Parent Johnson & Johnson for ALZA CORPORATION. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2973, FLM/2:20-cv-00330, FLS/1:20-cv-23144, FLS/1:20-cv-23380, MOW/4:20-cv-00543, MOW/4:20-cv-00544, NJ/3:20-cv-10341, NJ/3:20-cv-10342, NJ/3:20-cv-11440, NJ/3:20-cv-12421, PAE/2:20-cv-04053 (Hurley, Robert) Modified on 10/9/2020 (TF). REMOVED DUPLICATE PARTIES.
October 8, 2020 Filing 4 NOTICE OF APPEARANCE re: pldg.( #1 in MDL No. 2973) Filed by Raymond C Silverman on behalf of Plaintiffs Joanne Jackson, #et al.ELIZABETH LAFAVE, Antigone Montgomery #[Suppress List] (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2973, CAS/3:20-cv-01266, FLS/1:20-cv-23380, NJ/3:20-cv-12421 (Silverman, Raymond)
October 8, 2020 Filing 3 NOTICE OF APPEARANCE re: pldg.( 1 in MDL No. 2973) Filed by Robert Bruce Hurley, Jr on behalf of Defendants ALZA CORPORATION, CENTOCOR RESEARCH & DEVELOPMENT, INC., JANSSEN ORTHO LLC, JANSSEN PHARMACEUTICALS, INC., JANSSEN RESEARCH & DEVELOPMENT LLC, ORTHO-MCNEIL PHARMACEUTICALS, INC., JOHNSON & JOHNSON, BAYER CORPORATION, BAYER HEALTHCARE LLC, BAYER HEALTHCARE PHARMACEUTICALS, INC., AND BAYER US LLC. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2973 et al. (Hurley, Robert) Modified on 10/9/2020 (TF). REMOVED DUPLICATE PARTIES.
September 24, 2020 Filing 2 ***TEXT ONLY NOTICE***NOTICE OF FILING AND PUBLICATION OF BRIEFING SCHEDULE re: pldg. ( #1 in MDL No. 2973) BRIEFING SCHEDULE IS SET AS FOLLOWS: Notices of Appearance due on or before 10/8/2020. Corporate Disclosure Statements due on or before 10/8/2020. Responses due on or before 10/15/2020. Reply, if any, due on or before 10/22/2020. In their briefs, the parties should address what steps they have taken to pursue alternatives to centralization (including, but not limited to, engaging in informal coordination of discovery and scheduling, and seeking Section 1404 transfer of one or more of the subject cases). #Appearance forms (JPML form 18) and #Corporate Disclosure forms can be downloaded from our website. Important: A Corporate Disclosure Form, if required, must be filed, even if one has previously been filed in this MDL.Please visit the #CM/ECF Filing Guidelines & Forms page of our website for additional information.Signed by Clerk of the Panel John W. Nichols on 9/24/2020. Associated Cases: MDL No. 2973, ALN/2:20-cv-00993, CAS/3:20-cv-01266, FLM/2:20-cv-00330, FLM/5:20-cv-00390, FLS/0:20-cv-61721, FLS/1:20-cv-23144, FLS/1:20-cv-23380, FLS/1:20-cv-23500, MOW/4:20-cv-00543, MOW/4:20-cv-00544, NCM/1:20-cv-00718, NCM/1:20-cv-00769, NJ/2:20-cv-07079, NJ/3:20-cv-06070, NJ/3:20-cv-07750, NJ/3:20-cv-07753, NJ/3:20-cv-07756, NJ/3:20-cv-07758, NJ/3:20-cv-08074, NJ/3:20-cv-09530, NJ/3:20-cv-10080, NJ/3:20-cv-10341, NJ/3:20-cv-10342, NJ/3:20-cv-10960, NJ/3:20-cv-10966, NJ/3:20-cv-10968, NJ/3:20-cv-11440, NJ/3:20-cv-11912, NJ/3:20-cv-11913, NJ/3:20-cv-11919, NJ/3:20-cv-11921, NJ/3:20-cv-12264, NJ/3:20-cv-12328, NJ/3:20-cv-12421, NJ/3:20-cv-12605, NJ/3:20-cv-12608, OHN/4:20-cv-01984, OHS/1:20-cv-00675, PAE/2:20-cv-02147, PAE/2:20-cv-02150, PAE/2:20-cv-02183, PAE/2:20-cv-02207, PAE/2:20-cv-02234, PAE/2:20-cv-02871, PAE/2:20-cv-03056, PAE/2:20-cv-03345, PAE/2:20-cv-04021, PAE/2:20-cv-04024, PAE/2:20-cv-04053, PAE/2:20-cv-04133, PAE/2:20-cv-04153, PAE/2:20-cv-04157, PAE/2:20-cv-04158, PAE/2:20-cv-04160, PAE/2:20-cv-04162, PAE/2:20-cv-04179, PAE/2:20-cv-04389, PAE/2:20-cv-04394, PAE/2:20-cv-04397, PAE/2:20-cv-04423, PAE/2:20-cv-04488, WIE/2:20-cv-01256, WIE/2:20-cv-01309 (LH)
September 24, 2020 Filing 1 MDL Number 2973 Assigned -- MOTION FOR TRANSFER ACCEPTED FOR FILING re: pldg. ( #1 in Pending No. 135) Associated Cases: Pending No. 135, ALN/2:20-cv-00993, CAS/3:20-cv-01266, FLM/2:20-cv-00330, FLM/5:20-cv-00390, FLS/0:20-cv-61721, FLS/1:20-cv-23144, FLS/1:20-cv-23380, FLS/1:20-cv-23500, MOW/4:20-cv-00543, MOW/4:20-cv-00544, NCM/1:20-cv-00718, NCM/1:20-cv-00769, NJ/2:20-cv-07079, NJ/3:20-cv-06070, NJ/3:20-cv-07750, NJ/3:20-cv-07753, NJ/3:20-cv-07756, NJ/3:20-cv-07758, NJ/3:20-cv-08074, NJ/3:20-cv-09530, NJ/3:20-cv-10080, NJ/3:20-cv-10341, NJ/3:20-cv-10342, NJ/3:20-cv-10960, NJ/3:20-cv-10966, NJ/3:20-cv-10968, NJ/3:20-cv-11440, NJ/3:20-cv-11912, NJ/3:20-cv-11913, NJ/3:20-cv-11919, NJ/3:20-cv-11921, NJ/3:20-cv-12264, NJ/3:20-cv-12328, NJ/3:20-cv-12421, NJ/3:20-cv-12605, NJ/3:20-cv-12608, OHN/4:20-cv-01984, OHS/1:20-cv-00675, PAE/2:20-cv-02147, PAE/2:20-cv-02150, PAE/2:20-cv-02183, PAE/2:20-cv-02207, PAE/2:20-cv-02234, PAE/2:20-cv-02871, PAE/2:20-cv-03056, PAE/2:20-cv-03345, PAE/2:20-cv-04021, PAE/2:20-cv-04024, PAE/2:20-cv-04053, PAE/2:20-cv-04133, PAE/2:20-cv-04153, PAE/2:20-cv-04157, PAE/2:20-cv-04158, PAE/2:20-cv-04160, PAE/2:20-cv-04162, PAE/2:20-cv-04179, PAE/2:20-cv-04389, PAE/2:20-cv-04394, PAE/2:20-cv-04397, PAE/2:20-cv-04423, PAE/2:20-cv-04488, WIE/2:20-cv-01256, WIE/2:20-cv-01309 (LH)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Judicial Panel on Multidistrict Litigation's Electronic Court Filings (ECF) System

Search for this case: Montgomery v. TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC. et al
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Montgomery
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Antigone Montgomery
Represented By: Raymond C Silverman
Represented By: Francisco Antonio Albites, Jr.
Represented By: Melanie H. Muhlstock
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Bayer Healthcare Pharmaceuticals Inc.
Represented By: Tracie J Renfroe
Represented By: Robert Bruce Hurley, Jr
Represented By: BAYER HEALTHCARE PHARMACEUTICALS INC.
Represented By: Kristen R. Fournier
Represented By: David J. Walz
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Ivax LLC
Represented By: Ivax LLC
Represented By: Daniel Jay Gerber
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: JANSSEN PHARMACEUTICALS, INC.
Represented By: Johnson & Johnson
Represented By: Janssen Pharmaceutica Inc. n/k/a Janssen Pharmaceu
Represented By: Tracie J Renfroe
Represented By: Robert Bruce Hurley, Jr
Represented By: Janssen Pharamaceuticals, Inc.
Represented By: Kristen R. Fournier
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC.
Represented By: Teva Branded Pharmaceutical Products R&D, Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Janssen Research & Development, LLC
Represented By: Tracie J Renfroe
Represented By: Robert Bruce Hurley, Jr
Represented By: Kristen R. Fournier
Represented By: Janssen Research & Development, LLC
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: ORTHO-MCNEIL PHARMACEUTICALS, LLC
Represented By: Tracie J Renfroe
Represented By: Robert Bruce Hurley, Jr
Represented By: ORTHO-MCNEIL PHARMACEUTICALS, LLC
Represented By: Kristen R. Fournier
Represented By: David J. Walz
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Teva Global Respiratory Research, LLC
Represented By: Teva Branded Pharmaceutical Products R&D, Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Centocor Research & Development Inc
Represented By: Tracie J Renfroe
Represented By: Robert Bruce Hurley, Jr
Represented By: Centocor Research & Development, Inc.
Represented By: Kristen R. Fournier
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Ortho-McNeil-Janssen Pharmaceuticals, Inc
Represented By: Janssen Pharmaceutica Inc. n/k/a Janssen Pharmaceu
Represented By: Tracie J Renfroe
Represented By: Robert Bruce Hurley, Jr
Represented By: Janssen Pharamaceuticals, Inc.
Represented By: Kristen R. Fournier
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Ivax Corporation
Represented By: Ivax LLC
Represented By: Daniel Jay Gerber
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Alza Corporation
Represented By: Tracie J Renfroe
Represented By: Robert Bruce Hurley, Jr
Represented By: Alza Corporation
Represented By: Kristen R. Fournier
Represented By: David J. Walz
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Johnson & Johnson Research & Development, L.L.C
Represented By: Tracie J Renfroe
Represented By: Robert Bruce Hurley, Jr
Represented By: Kristen R. Fournier
Represented By: Janssen Research & Development, LLC
Represented By: David J. Walz
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Bayer Pharmaceuticals Corporation
Represented By: Tracie J Renfroe
Represented By: Robert Bruce Hurley, Jr
Represented By: BAYER HEALTHCARE PHARMACEUTICALS INC.
Represented By: Kristen R. Fournier
Represented By: David J. Walz
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Janssen Ortho LLC
Represented By: Tracie J Renfroe
Represented By: Robert Bruce Hurley, Jr
Represented By: Janssen Ortho, LLC
Represented By: Kristen R. Fournier
Represented By: David J. Walz
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D INC
Represented By: Teva Branded Pharmaceutical Products R&D, Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Janssen Research and Developement, LLC
Represented By: Robert Bruce Hurley, Jr
Represented By: Kristen R. Fournier
Represented By: Tracie J Renfroe
Represented By: David J. Walz
Represented By: Janssen Research & Development, LLC
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Janssen Pharmaceuticals Inc.
Represented By: Robert Bruce Hurley, Jr
Represented By: Tracie J Renfroe
Represented By: Janssen Pharmaceutica Inc. n/k/a Janssen Pharmaceu
Represented By: Janssen Pharamaceuticals, Inc.
Represented By: David J. Walz
Represented By: Kristen R. Fournier
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: ORTHO- MCNEIL-JANSSEN PHARMACEUTICALS, INC. nka JANSSEN PHARMACEUTICALS, INC.
Represented By: Janssen Pharamaceuticals, Inc.
Represented By: David J. Walz
Represented By: Kristen R. Fournier
Represented By: Robert Bruce Hurley, Jr
Represented By: Tracie J Renfroe
Represented By: Janssen Pharmaceutica Inc. n/k/a Janssen Pharmaceu
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Johnson & Johnson
Represented By: Kristen R. Fournier
Represented By: Tracie J Renfroe
Represented By: Johnson & Johnson
Represented By: David J. Walz
Represented By: Robert Bruce Hurley, Jr
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Centocor Research & Development, Inc.
Represented By: David J. Walz
Represented By: Tracie J Renfroe
Represented By: Centocor Research & Development, Inc.
Represented By: Kristen R. Fournier
Represented By: Robert Bruce Hurley, Jr
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Bayer Healthcare, LLC
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.

Why Is My Information Online?